Concepedia

Access-oriented Medicine Selection

Access-Oriented Medicine Selection is a medicine selection policy framework that prioritizes equitable availability and affordability of essential medicines by systematically incorporating access-related criteria—such as cost, supply chain feasibility, and healthcare infrastructure compatibility—into the decision-making process to distinguish it from efficacy- or cost-effectiveness-focused selection models.

8

Publications

357

Citations

38

Authors

23

Institutions

Publications per year

2017–2026

2

Parents

Publications

8

Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey

Adam Fundytus, Manju Sengar, Dorothy Lombe et al. · The Lancet Oncology · 2021 · 171 citations · Full text

, , +13

Selection of oncology medicines in low- and middle-income countries

Y. T. Bazargani, A. de Boer, J. H. M. Schellens et al. · Annals of Oncology · 2013 · 41 citations

, , +13

The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Countries: The Case of Tanzania

Amani Thomas Mori, Eliangiringa Kaale, Frida Ngalesoni et al. · PLoS ONE · 2014 · 36 citations · Full text

, , +14

Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists

Y. T. Bazargani, Anthonius de Boer, Hubert G. M. Leufkens et al. · PLoS ONE · 2014 · 30 citations · Full text

, , +16

Access and Selection

Glen Bandiera, Jerry M Maniate, Mark D. Hanson et al. · Academic Medicine · 2015 · 27 citations · Full text

, , +17

1–5 of 8

Authors

38

  1. DL
    Dorothy Lombe

    Queen's University, Canada

    2 publications · 186 citations

    2

    h-index

  2. EG
    Elisabeth G.E. de Vries

    University Medical Center Groningen, Netherlands

    2 publications · 186 citations

    2

    h-index

  3. BG
    Bishal Gyawali

    Queen's University, Canada

    2 publications · 186 citations

    2

    h-index

  4. MJ
    Matthew Jalink

    Queen's University, Canada

    2 publications · 186 citations

    2

    h-index

  5. AF
    Adam Fundytus

    Queen's University, Canada

    2 publications · 186 citations

    2

    h-index

1–5 of 38

Institutions

23

  1. World Health Organization

    Geneva, Switzerland

    3 h-index

    7 publications

    570 citations

  2. Queen's University

    Kingston, Canada

    2 h-index

    10 publications

    930 citations

  3. University Medical Center Groningen

    Groningen, The Netherlands

    2 h-index

    2 publications

    186 citations

  4. Utrecht University

    Utrecht, The Netherlands

    2 h-index

    9 publications

    325 citations

  5. European Institute of Oncology

    Milan, Italy

    2 h-index

    2 publications

    186 citations

  6. King's College London

    London, United Kingdom

    2 h-index

    2 publications

    186 citations

  7. Tata Memorial Hospital

    Mumbai, India

    2 h-index

    3 publications

    201 citations

  8. University of Groningen

    Groningen, The Netherlands

    2 h-index

    2 publications

    186 citations

1–8 of 23

Venues

  1. PLoS ONE

    2 publications · 66 citations

    2

    h-index

  2. 1

    h-index

  3. PubMed

    Repository · 1 publications · 12 citations

    1

    h-index

  4. JCO Global Oncology

    1 publications · 15 citations

    1

    h-index

  5. The Lancet Oncology

    1 publications · 171 citations

    1

    h-index

1–5